We are live on ! Find out more
WA

Win Advisors Portfolio holdings

AUM $219M
1-Year Est. Return 43.69%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+43.69%
3 Year Est. Return
+114.14%
5 Year Est. Return
10 Year Est. Return
AUM
$51M
AUM Growth
-$330M
Cap. Flow
-$299M
Cap. Flow %
-586.3%
Top 10 Hldgs %
85.24%
Holding
223
New
17
Increased
71
Reduced
57
Closed
58
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
126
BCE
BCE
$20.8B
$7K 0.01%
134
+67
+100% +$3.6K
MRNA icon
127
Moderna
MRNA
$21.6B
$7K 0.01%
44
-1,149
-96% -$164K
NWE icon
128
NorthWestern Energy
NWE
$4.34B
$7K 0.01%
109
+49
+82% +$2.92K
PGR icon
129
Progressive
PGR
$128B
$7K 0.01%
59
-1,568
-96% -$178K
QUAL icon
130
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$7K 0.01%
62
A icon
131
Agilent Technologies
A
$39.6B
$6K 0.01%
47
-1,269
-96% -$156K
AAPL icon
132
Apple
AAPL
$4.97T
$6K 0.01%
45
GILD icon
133
Gilead Sciences
GILD
$165B
$6K 0.01%
102
+45
+79% +$2.79K
MTB icon
134
M&T Bank
MTB
$36.3B
$6K 0.01%
38
-959
-96% -$161K
SLB icon
135
SLB Ltd
SLB
$72.7B
$6K 0.01%
166
-4,357
-96% -$182K
VZ icon
136
Verizon
VZ
$197B
$6K 0.01%
119
+53
+80% +$2.68K
HZNP
137
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6K 0.01%
71
DOX icon
138
Amdocs
DOX
$6.03B
$5K 0.01%
+59
New +$4.86K
FCX icon
139
Freeport-McMoran
FCX
$86.2B
$5K 0.01%
157
FITB
140
Fifth Third Bancorp
FITB
$51.3B
$5K 0.01%
142
-3,642
-96% -$137K
NUE icon
141
Nucor
NUE
$58.3B
$5K 0.01%
51
-2,369
-98% -$321K
OGN icon
142
Organon & Co
OGN
$3.56B
$5K 0.01%
145
-3,696
-96% -$129K
MU icon
143
Micron Technology
MU
$835B
$4K 0.01%
79
-1,916
-96% -$130K
SPGP icon
144
Invesco S&P 500 GARP ETF
SPGP
$2.25B
$4K 0.01%
53
-51,591
-100% -$4.4M
INGR icon
145
Ingredion
INGR
$6.42B
$3K 0.01%
31
-8
-21% -$716
MTUM icon
146
iShares MSCI USA Momentum Factor ETF
MTUM
$23.6B
$3K 0.01%
25
-34,468
-100% -$5.06M
SBUX icon
147
Starbucks
SBUX
$119B
$3K 0.01%
+40
New +$3.07K
VGT icon
148
Vanguard Information Technology ETF
VGT
$133B
$3K 0.01%
72
-29,688
-100% -$1.34M
ARKG icon
149
ARK Genomic Revolution ETF
ARKG
$1.53B
$2K ﹤0.01%
75
BIL icon
150
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$1K ﹤0.01%
7

Similar funds

Win Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Win Advisors held 223 positions worth $51M, down 87% from $381M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Win Advisors withdrew a net $299M in Q2 2022, closing 58 positions and reducing 57 holdings. Its most notable exit was State Street SPDR US Large Cap Low Volatility Index ETF, an estimated $25.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 1.3% of assets, up from 0.08% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Win Advisors opened a new position in ProShares Short 20+ Year Treasury ETF worth $18.1M.

  • Win Advisors's largest Q2 2022 buy was ProShares Short 20+ Year Treasury ETF: 911,802 shares worth $18.1M.
  • Win Advisors added most to Vanguard Materials ETF in Q2 2022, an estimated $746K increase.
  • Win Advisors's biggest Q2 2022 reduction was First Trust Large Cap Core AlphaDEX Fund, cutting an estimated $25.6M.
  • Win Advisors fully exited State Street SPDR US Large Cap Low Volatility Index ETF in Q2 2022, selling an estimated $25.6M.
  • Win Advisors's ten largest holdings make up 85% of its $51M portfolio in Q2 2022.
  • Win Advisors opened 17 new positions and closed 58 in Q2 2022.
  • Win Advisors's portfolio value fell 87% quarter-over-quarter to $51M.

Based on Win Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.